scholarly journals Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: open‐label extension of the NOR‐SWITCH trial

2019 ◽  
Vol 285 (6) ◽  
pp. 653-669 ◽  
Author(s):  
G. L. Goll ◽  
K. K. Jørgensen ◽  
J. Sexton ◽  
I. C. Olsen ◽  
N. Bolstad ◽  
...  
Keyword(s):  
Switch Trial ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension

scholarly journals Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study

2022 ◽  
Vol 239 ◽  
pp. 83-91
Author(s):  
Yuriy Filts ◽  
Robert E. Litman ◽  
Javier Martínez ◽  
Lourdes Anta ◽  
Dieter Naber ◽  
...  
Keyword(s):  
Extension Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension

P150 LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY

2020 ◽  
Vol 125 (5) ◽  
pp. S21
Author(s):  
A. Banerji ◽  
J. Hao ◽  
M. Yu ◽  
J. Bernstein ◽  
D. Johnston ◽  
...  
Keyword(s):  
Extension Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension

scholarly journals Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study

2008 ◽  
Vol 62 (10) ◽  
pp. 1499-1510 ◽  
Author(s):  
D. Lütjohann ◽  
K. Von Bergmann ◽  
W. Sirah ◽  
G. Macdonell ◽  
A. O. Johnson-Levonas ◽  
...  
Keyword(s):  
Extension Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension

scholarly journals Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study

2021 ◽  
Author(s):  
Philippe Gevaert ◽  
Rebecca Saenz ◽  
Jonathan Corren ◽  
Joseph K. Han ◽  
Joaquim Mullol ◽  
...  
Keyword(s):  
Nasal Polyposis ◽  
Extension Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension
Sign in / Sign up

Export Citation Format

Share Document